Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 26th:
XPEL, Inc. (XPEL) : This provider manufacturer and seller of after-market automotive products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.4% over the last 60 days.
XPEL's shares gained 63.3% over the last one month compared to S&P 500’s rise of 5%. The company possesses a Momentum Score of A.
La-Z-Boy Incorporated (LZB) : This manufacturer and distributor of upholstery furniture products, accessories, and casegoods furniture products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 64.3% over the last 60 days.
La-Z-Boy's shares gained 19.2% over the last one month. The company possesses a Momentum Score of A.
Medpace Holdings, Inc. (MEDP) : This provider of scientifically-driven outsourced clinical development service has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 67.2% over the last 60 days.
Medpace's shares gained 16.9% over the last one month. The company possesses a Momentum Score of A.
Read Next: Man who made EIGHTEEN 1,000% recommendations unveils #1 stock
Most people will go their whole lives without capturing a 1,000% gain in stocks.
But one man from rural PA may have cracked the code.
11 years ago, millionaire early stage investor Matt McCall shared some of his first recommendations with the public, live on air.
The anchors laughed in his face…
Since then, McCall has built one of the greatest track records in the financial world.
He's pinpointed dozens of stocks that went on to jump 100% or more.
Plus 18 recommendations that skyrocketed over 1,000%.
McCall just teamed up with one of the biggest names in finance to reveal the name and ticker symbol of what he predicts will be the best-performing stock of 2020.
“I'm confident that this is my next big winner — and I haven't felt this way since back in 2009. This company is on the cutting-edge of one of the greatest medical breakthroughs of the 21st century. You can't afford to ignore this.”
To see McCall's newest prediction for yourself, simply go here.
You'll get this stock's name and ticker symbol, absolutely free.